Walker Luke Nathaniel 4
4 · Context Therapeutics Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Director
Transactions
- Award
Stock Option (right to buy)
2024-09-04+19,315→ 19,315 totalExercise: $2.43Exp: 2034-09-03→ Common Stock (19,315 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.